Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Surg Oncol Clin N Am. 2013 Jul 24;22(4):805–821. doi: 10.1016/j.soc.2013.06.001

Figure 2.

Figure 2

Overall survival for study population of EORTC 62005 compared with historical controls from EORTC database.

From Verweij J, Casali PG, Zalcberg J, et al. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomized trial*. The Lancet. 2004; 364(9440):1127–1134; with permission.